Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 1,775 shares of common stock on 11/19/2024, as per the latest filing. The shares, valued at an aggregate market value of $17,190, were acquired on 11/18/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a recent sale of 5,015 shares in the past three months, which had gross proceeds of $43,551.